Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare Revenues Increase 12 Percent in Q2

NEW YORK, July 15 (GenomeWeb News) - GE Healthcare's revenues during the second quarter of 2005 increased 12 percent year over year, to $3.8 billion, GE reported today.


The business unit, which incorporated Amersham Biosciences in April of last year, contributed 9 percent to GE's overall quarterly revenues of $41.6 billion, similar to the same period in 2004. GE's total revenues were up 13 percent over last year's $36.8 billion during the second quarter.


Orders for the healthcare business unit grew 11 percent over the second quarter of 2004, to $3.9 billion, $2.5 billion of which came from equipment orders.


Healthcare had $672 million in profits, up 15 percent from $584 million during the same period last year.


GE's total earnings amounted to $4.6 billion, up 24 percent from $3.8 billion in the second quarter of last year. Earnings per share were $.44, up 22 percent over last year's $.36 during the same period.


As of June 30, GE had $146 billion in cash and marketable securities.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.